News

Video

Mortality and Causes of Death in Patients With Polycythemia Vera

Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on what polycythemia vera (PV) is and why it was important to understand mortality and causes of death among patients with PV.

Pharmacy Times® interviewed Brady Stein, MD, MHSc, an associate professor of medicine in hematology and oncology at the Feinberg School of Medicine at Northwestern University, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses a multicenter, noninterventional, prospective observational study of patients with polycythemia vera (PV) in US clinical practices, specifically in relation to mortality and causes of death.

In this video, Stein defines PV and explains why it was important to understand mortality and causes of death among patients with PV.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com